Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 5785-5792

  Monti, Paolo ^a   Scirpoli, Miriam ^a   Rigamonti, Andrea ^a   Mayr, Anya ^b   Jaeger, Annika ^b   Bonfanti, Riccardo ^a   Chiumello, Giuseppe ^a   Ziegler, Anette G ^b   Bonifacio, Ezio ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RO ANTIGEN; GLUTAMATE DECARBOXYLASE 65; HLA ANTIGEN; INSULIN; 5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; AUTOANTIGEN; CD45 ANTIGEN; FLUORESCEIN DERIVATIVE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; EVIDENCE BASED PRACTICE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOREACTIVITY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TELOMERE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INDICATOR DILUTION CURVE; METABOLISM; PHENOTYPE; RISK FACTOR; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD45; AUTOANTIGENS; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCEINS; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOLOGIC MEMORY; INDICATOR DILUTION TECHNIQUES; INSULIN; MALE; PHENOTYPE; RISK FACTORS; SUCCINIMIDES; T-LYMPHOCYTES; TELOMERE;

EID: 38449111219     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.5785     Document Type: Article

References (27)

1. Atkinson, M. A., and G. S. Eisenbarth. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358: 221-229.
2. Gianani, R., and G. S. Eisenbarth. 2005. The stages of type 1A diabetes: 2005. Immunol. Rev. 204: 232-249.
3. Roep, B. O. 2003. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 305-321.
4. Atkinson, M. A., D. L. Kaufman, L. Campbell, K. A. Gibbs, S. C. Shah, D. F. Bu, M. G. Erlander, A. J. Tobin, and N. K. Maclaren. 1992. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458-459.
5. Kelemen, K., P. A. Gottlieb, A. L. Putnam, H. W. Davidson, D. R. Wegmann, and J. C. Hutton. 2004. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 β) in human prediabetes. J. Immunol. 172: 3955-3962.
6. Alleva, D. G., P. D. Crowe, L. Jin, W. W. Kwok, N. Ling, M. Gottschalk, P. J. Conlon, P. A. Gottlieb, A. L. Putnam, and A. Gaur. 2001. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J. Clin. Invest. 107: 173-180.
7. Achenbach, P., K. Koczwara, A. Knopff, H. Naserke, A. G. Ziegler, and E. Bonifacio. 2004. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J. Clin. Invest. 114: 589-597.
8. Bonifacio, E., V. Lampasona, S. Genovese, M. Ferrari, and E. Bosi. 1995. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155: 5419-5426.
9. Achenbach, P., K. Warncke, J. Reiter, A. J. Williams, A. G. Ziegler, P. J. Bingley, and E. Bonifacio. 2006. Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives. Diabetologia. 49: 2969-2976.
10. + T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J. Autoimmun. 25: 235-243.
11. Reijonen, H., E. J. Novak, S. Kochik, A. Heninger, A. W. Liu, W. W. Kwok, and G. T. Nepom. 2002. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51: 1375-1382.
12. Seyfert-Margolis, V., T. D. Gisler, A. L. Asare, R. S. Wang, H. M. Dosch, B. Brooks-Worrell, G. S. Eisenbarth, J. P. Palmer, C. J. Greenbaum, S. E. Gitelman, et al. 2006. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55: 2588-2594.
13. Roep, B. O. 1999. Standardization of T-cell assays in type I diabetes. Immunology of Diabetes Society T-Cell Committee. Diabetologia 42: 636-637.
14. Viglietta, V., S. C. Kent, T. Orban, and D. A. Hafler. 2002. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 109: 895-903.
15. Endl, J., S. Rosinger, B. Schwarz, S. O. Friedrich, G. Rothe, W. Karges, M. Schlosser, T. Eiermann, D. J. Schendel, and B. O. Boehm. 2006. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 55: 50-60.
16. Slagboom, P. E., S. Droog, and D. I. Boomsma. 1994. Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet. 55: 876-882.
17. Weng, N. P., B. L. Levine, C. H. June, and R. J. Hodes. 1995. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA 92: 11091-11094.
18. Lingner, J., T. R. Hughes, A. Shevchenko, M. Mann, V. Lundblad, and T. R. Cech. 1997. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276: 561-567.
19. Rufer, N., W. Dragowska, G. Thornbury, E. Roosnek, and P. M. Lansdorp. 1998. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol. 16: 743-747.
20. Mannering, S. I., J. S. Morris, K. P. Jensen, A. W. Purcell, M. C. Honeyman, P. M. van Endert, and L. C. Harrison. 2003. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J. Immunol. Methods 283: 173-183.
21. Panina-Bordignon, P., R. Lang, P. M. van Endert, E. Benazzi, A. M. Felix, R. M. Pastore, G. A. Spinas, and F. Sinigaglia. 1995. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 181: 1923-1927.
22. Roep, B. O. 1999. Standardization of T-cell assays in type I diabetes. Immunology of Diabetes Society T-Cell Committee. Diabetologia 42: 636-637.
23. Arif, S., T. I. Tree, T. P. Astill, J. M. Tremble, A. J. Bishop, C. M. Dayan, B. O. Roep, and M. Peakman. 2004. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113: 451-463.
24. + T cells in healthy and type 1 diabetic subjects. J. Autoimmun. 25: 303-311.
25. Moulton, V. R., and D. L. Farber. 2006. Committed to memory: lineage choices for activated T cells. Trends. Immunol. 27: 261-267.
26. high T cells gives rise to homogeneous regulatory T cell lines upon in vitro expansion. Blood 108: 4260-4267.
27. Tang, Q., and J. A. Bluestone. 2006. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212: 217-237.